FR2547813B1 - 3-(3-hydroxybutoxy)-1-butanol et sa preparation - Google Patents

3-(3-hydroxybutoxy)-1-butanol et sa preparation

Info

Publication number
FR2547813B1
FR2547813B1 FR848408571A FR8408571A FR2547813B1 FR 2547813 B1 FR2547813 B1 FR 2547813B1 FR 848408571 A FR848408571 A FR 848408571A FR 8408571 A FR8408571 A FR 8408571A FR 2547813 B1 FR2547813 B1 FR 2547813B1
Authority
FR
France
Prior art keywords
hydroxybutoxy
butanol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR848408571A
Other languages
English (en)
French (fr)
Other versions
FR2547813A1 (fr
Inventor
Elso Manghisi
Aldo Salimbeni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Publication of FR2547813A1 publication Critical patent/FR2547813A1/fr
Application granted granted Critical
Publication of FR2547813B1 publication Critical patent/FR2547813B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR848408571A 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation Expired FR2547813B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (2)

Publication Number Publication Date
FR2547813A1 FR2547813A1 (fr) 1984-12-28
FR2547813B1 true FR2547813B1 (fr) 1989-01-27

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
FR848408571A Expired FR2547813B1 (fr) 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation

Country Status (8)

Country Link
US (1) US4584321A (enExample)
JP (1) JPS604146A (enExample)
BE (1) BE899790A (enExample)
DE (1) DE3419947A1 (enExample)
ES (1) ES8507449A1 (enExample)
FR (1) FR2547813B1 (enExample)
GB (1) GB2142623B (enExample)
IT (1) IT1164254B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101165036A (zh) 1999-04-01 2008-04-23 埃斯佩里安医疗公司 醚化合物,及其组合物和用途
BR0114619A (pt) 2000-10-11 2005-12-13 Esperion Therapeutics Inc Composto, composição farmacêutica, métodos para tratar ou prevenir uma doença cardiovascular, uma dislipidemia, uma dislipoproteinemia, um distúrbio do metabolismo da glicose, trombótico e associado com o receptor ativado do proliferador de peroxissoma, a doença de alzheimer, a sìndrome x ou sìndrome metabólica, a septicemia, a obesidade, pancreatite, a hipertensão, doença renal, câncer, a inflamação e a impotência, em um paciente e para reduzir o teor de gordura da carne em animal de criação e de colesterol de ovos de aves domésticas
CA2425678A1 (en) 2000-10-11 2002-04-18 Jean-Louis H. Dasseux Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
AU2002213136B2 (en) 2000-10-11 2007-01-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
MXPA03003021A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
BR0309152A (pt) * 2002-04-10 2007-01-30 Esperion Therapeutics Inc composto ou sais, solvatos, hidratos ou pró-drogas deste farmaceuticamente aceitáveis, composição, métodos para tratar ou prevenir uma doença ou condição, uma doença cardiovascular, uma dislipidemia, a hipertensão, o cáncer, a inflamação, e a impotência em um paciente, forma de dosagem unitária, e, método para identificar um composto útil para tratar ou prevenir uma condição em um paciente
HUE036646T2 (hu) * 2003-01-23 2018-07-30 Esperion Therapeutics Inc Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra
JP2007525408A (ja) 2003-12-24 2007-09-06 エスペリオン セラピューティクス，インコーポレイテッド コレステロール管理および関連使用のためのケトン化合物および組成物
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
CN107530307A (zh) 2015-03-13 2018-01-02 艾斯柏伦治疗公司 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
BR112021025928A2 (pt) 2019-06-21 2022-05-10 Esperion Therapeutics Inc Métodos de preparação de ácido bempedoico e composições do mesmo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
IT1164254B (it) 1987-04-08
ES532802A0 (es) 1985-10-01
FR2547813A1 (fr) 1984-12-28
JPS604146A (ja) 1985-01-10
IT8321352A1 (it) 1984-11-30
IT8321352A0 (it) 1983-05-30
DE3419947A1 (de) 1984-12-06
BE899790A (fr) 1984-11-30
GB2142623B (en) 1987-04-15
GB8411356D0 (en) 1984-06-06
US4584321A (en) 1986-04-22
ES8507449A1 (es) 1985-10-01
JPS6241702B2 (enExample) 1987-09-04
DE3419947C2 (enExample) 1987-11-26
GB2142623A (en) 1985-01-23

Similar Documents

Publication Publication Date Title
FR2547813B1 (fr) 3-(3-hydroxybutoxy)-1-butanol et sa preparation
IT1167391B (it) Carbossi e carbossi sostituiti alcanoil e cicloalcanoil peptidi
NO813290L (no) Nytt benzotiazinderivat og anvendelse derav for fremstilling av piroxicam
DK376183D0 (da) 3-phenoxy-1-azetidincarboxamider samt deres fremstilling
FR2557471B1 (fr) Capsule absorbante et notamment deshydratante
DK614084A (da) Milbemycim-derivater samt deres fremstilling og anvendelse
DK162804C (da) Dinitroanilinpraeparat samt dettes fremstilling
FI810977L (fi) Fram- och aotergaoende skaerningsfoerfarande och anordning med vaexlande roerelse
FI820051L (fi) Pyridinyl-substituerade benzimidazol-derivat och deras framstaellning
DK558484A (da) Milbemycinderivater samt deres fremstilling og anvendelse
DK556483A (da) Benzofuranylderivater og deres fremstilling
DK189584D0 (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK419084D0 (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
FR2522936B1 (fr) Friandise fouettee et sa preparation
DK356481A (da) Hetero-prostaglandinderivater og deres fremstilling
DK35984A (da) Lactampeptider samt deres fremstilling og anvendelse
DK522883D0 (da) 2-heterocyclythio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK613984D0 (da) 2-heterocyclyl-6-hydroxylavalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
IT8319872A0 (it) 3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione.
DE3475192D1 (de) Pyrrolizidinones and indolizidones
IT8220039A0 (it) 3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione.
IT8229577V0 (it) Dry people
NO834201L (no) Munnpleiepreparat
FI832821A0 (fi) Isskrapa foer rengoering av foenster och torkare
ES523392A0 (es) Procedimiento y dispositivo para convertir sonidos en colores-luz